End-of-day quote
Shanghai S.E.
06:00:00 2024-05-23 pm EDT
|
5-day change
|
1st Jan Change
|
7.42
CNY
|
+0.41%
|
|
-7.71%
|
+12.77%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,927
|
2,488
|
3,705
|
5,492
|
3,478
|
3,478
|
Enterprise Value (EV)
1 |
1,551
|
2,022
|
2,570
|
4,771
|
1,965
|
3,785
|
P/E ratio
|
20.3
x
|
15.1
x
|
12.5
x
|
11.2
x
|
-38.7
x
|
34.6
x
|
Yield
|
-
|
-
|
4.28%
|
0.96%
|
-
|
1.52%
|
Capitalization / Revenue
|
2.93
x
|
1.93
x
|
1.26
x
|
1.21
x
|
0.71
x
|
0.7
x
|
EV / Revenue
|
2.36
x
|
1.57
x
|
0.88
x
|
1.05
x
|
0.4
x
|
0.76
x
|
EV / EBITDA
|
11.1
x
|
5.94
x
|
5.02
x
|
5.25
x
|
6.26
x
|
8.27
x
|
EV / FCF
|
10.7
x
|
27.8
x
|
11.7
x
|
5.24
x
|
1.57
x
|
-2.06
x
|
FCF Yield
|
9.38%
|
3.6%
|
8.52%
|
19.1%
|
63.8%
|
-48.4%
|
Price to Book
|
1.53
x
|
1.76
x
|
1.38
x
|
1.82
x
|
1.2
x
|
1.16
x
|
Nbr of stocks (in thousands)
|
350,987
|
350,987
|
528,583
|
528,583
|
528,583
|
528,583
|
Reference price
2 |
5.490
|
7.090
|
7.010
|
10.39
|
6.580
|
6.580
|
Announcement Date
|
3/19/19
|
4/2/20
|
3/30/21
|
3/24/22
|
3/22/23
|
3/6/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
658
|
1,291
|
2,931
|
4,531
|
4,898
|
4,994
|
EBITDA
1 |
140.3
|
340.5
|
512.5
|
908.4
|
314.2
|
457.4
|
EBIT
1 |
100.9
|
282.7
|
379.3
|
744.7
|
69.42
|
189.5
|
Operating Margin
|
15.33%
|
21.91%
|
12.94%
|
16.44%
|
1.42%
|
3.79%
|
Earnings before Tax (EBT)
1 |
99.5
|
279.4
|
381.5
|
756.3
|
43.46
|
184.4
|
Net income
1 |
94.07
|
164.6
|
230.8
|
493.1
|
-88.3
|
101.4
|
Net margin
|
14.3%
|
12.76%
|
7.88%
|
10.88%
|
-1.8%
|
2.03%
|
EPS
2 |
0.2700
|
0.4700
|
0.5600
|
0.9300
|
-0.1700
|
0.1900
|
Free Cash Flow
1 |
145.5
|
72.76
|
218.9
|
911.3
|
1,254
|
-1,834
|
FCF margin
|
22.11%
|
5.64%
|
7.47%
|
20.12%
|
25.6%
|
-36.72%
|
FCF Conversion (EBITDA)
|
103.67%
|
21.37%
|
42.72%
|
100.33%
|
399.02%
|
-
|
FCF Conversion (Net income)
|
154.64%
|
44.2%
|
94.85%
|
184.82%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
0.3000
|
0.1000
|
-
|
0.1000
|
Announcement Date
|
3/19/19
|
4/2/20
|
3/30/21
|
3/24/22
|
3/22/23
|
3/6/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
307
|
Net Cash position
1 |
376
|
467
|
1,135
|
721
|
1,513
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.6708
x
|
Free Cash Flow
1 |
145
|
72.8
|
219
|
911
|
1,254
|
-1,834
|
ROE (net income / shareholders' equity)
|
7.5%
|
16.5%
|
10.9%
|
19.5%
|
0.79%
|
4.83%
|
ROA (Net income/ Total Assets)
|
3.75%
|
8.93%
|
5.45%
|
8.67%
|
0.63%
|
1.47%
|
Assets
1 |
2,506
|
1,844
|
4,237
|
5,686
|
-14,056
|
6,923
|
Book Value Per Share
2 |
3.580
|
4.030
|
5.080
|
5.720
|
5.470
|
5.660
|
Cash Flow per Share
2 |
0.9400
|
0.6900
|
2.050
|
1.770
|
3.770
|
4.700
|
Capex
1 |
74.8
|
118
|
295
|
412
|
324
|
370
|
Capex / Sales
|
11.37%
|
9.16%
|
10.06%
|
9.1%
|
6.62%
|
7.41%
|
Announcement Date
|
3/19/19
|
4/2/20
|
3/30/21
|
3/24/22
|
3/22/23
|
3/6/24
|
|
1st Jan change
|
Capi.
|
---|
| +12.77% | 542M | | +3.47% | 103B | | -8.74% | 61.43B | | +72.86% | 49.09B | | +15.48% | 38.46B | | +3.64% | 32.09B | | +13.29% | 20.39B | | +12.53% | 16.78B | | +15.34% | 14.76B | | +0.39% | 13.73B |
Other Commodity Chemicals
|